Sage Journals: Discover world-class research

Free access

Announcement

First published 2008-5

Prediction of Sustained Virological Response by Ribavirin Plasma Concentration at Week 4 of Therapy in Hepatitis C virus Genotype 1 Patients

Marianne Maynard, Pierre Pradat, Marie-Claude Gagnieu [...]

Antiviral Therapy

Free access

Research article

First published 2016-4

Randomized Controlled Trial of the NS5A Inhibitor Daclatasvir plus Pegylated Interferon and Ribavirin for HCV Genotype-4 (COMMAND-4)

Christophe Hézode, Laurent Alric, Ashley Brown [...]

Antiviral Therapy

Free access

Research article

First published 2009-5

Virological response at 4 weeks to predict outcome of hepatitis C treatment with pegylated interferon and ribavirin

Michelle Martinot-Peignoux, Sarah Maylin, Rami Moucari [...]

Antiviral Therapy

Retricted access

Research article

First published 2015-01

Impact of Vitamin D Supplementation on Sustained Virological Response in Chronic Hepatitis C Genotype 4 Patients Treated by Pegylated Interferon/Ribavirin

Gamal Esmat, Maissa El Raziky, Aisha Elsharkawy [...]

Journal of Interferon & Cytokine Research

Retricted access

Research article

First published 2016-01

Safety and Efficacy of Combined Treatment with Pegylated Interferon Alpha-2b and Ribavirin for HCV Genotype 4 in Children

Hanaa M. El-Karaksy, Engy A. Mogahed, Mona S. El-Raziky [...]

Journal of Interferon & Cytokine Research

Free access

Research article

First published 2007-5

Rapid virological response at week 4 predicts response to pegylated interferon plus ribavirin among HIV/HCV-coinfected patients

José A Mira, Bárbara Valera-Bestard, Ana Arizcorreta-Yarza [...]

Antiviral Therapy

Free access

Research article

First published 2007-4

The Magnitude of Week 4 HCV RNA Decay on Pegylated Interferon/Ribavirin Accurately Predicts Virological Failure in Patients with Genotype 1

Rafael Bárcena, Ana Moreno, Santos Del Campo [...]

Antiviral Therapy

Retricted access

Research article

First published 2017-11

Pharmacokinetics-Based Adjusted Versus Standard Dose of Ribavirin Does Not Improve Virologic Response Rates in Chronic Hepatitis C Genotype 4 Patients: A Randomized Controlled Trial

Ibrahim H. Altraif, Faisal Sanai, Mohammed A. Babatin [...]

Journal of Interferon & Cytokine Research

Free access

Review article

First published 2010-05

Review: New direct-acting antivirals in the development for hepatitis C virus infection

Paul J. Pockros

Therapeutic Advances in Gastroenterology

Open access

Review article

First published 2007

Effect of Ribavirin Alone or Combined with Silymarin on Carbon Tetrachloride Induced Hepatic Damage in Rats

Omar M.E. Abdel Salam, Amany A. Sleem, Enayat A. Omara [...]

Drug Target Insights

Search results